Market Research Logo

Europe Pulmonary Hypertension Market and Competitive Landscape – 2017

Europe Pulmonary Hypertension Market and Competitive Landscape – 2017

The latest research from Fore Pharma, Europe Pulmonary Hypertension Market and Competitive Landscape – 2017, provides comprehensive insights into Pulmonary Hypertension pipeline, epidemiology, market valuations, product sales, market forecast, product forecasts, and market shares. This study accurately estimates and forecast Pulmonary Hypertension market size and drug sales. This research also provides insights into Pulmonary Hypertension epidemiology and late stage pipeline.
The report is classified into nine sections – Pulmonary Hypertension overview with definitions, symptoms, etiology, diagnosis, treatment options; Pulmonary Hypertension pipeline insights covering late stage clinical trials pipeline; Pulmonary Hypertension prevalence trends by countries; Pulmonary Hypertension market size and forecast by countries, market events, trends; product sales and forecast by countries; market shares by countries. The research scope includes EU5 countries – Germany, France, Italy, Spain, UK, Europe.

Research Scope:

  • Pulmonary Hypertension pipeline: Find out the drugs in clinical trials for Pulmonary Hypertension by stages, phase 3 clinical trials, phase 2 clinical trials, and phase 1 clinical trials, by pharmacological class, by company
  • Pulmonary Hypertension epidemiology: Find out the prevalence of Pulmonary Hypertension by countries – Europe, Germany, France, Italy, Spain, UK, Japan; prevalence forecast to 2025
  • Pulmonary Hypertension products: Identify key products marketed and prescribed for Pulmonary Hypertension by brand name, by molecule, by company, by branded / generic, by countries – Europe, Germany, France, Italy, Spain, UK, Japan
  • Pulmonary Hypertension market size: Find out the market size for Pulmonary Hypertension drugs by countries – Europe, Germany, France, Italy, Spain, UK, Japan; Find out how the market advanced from 2012
  • Pulmonary Hypertension drug sales: Find out the sales of Pulmonary Hypertension drugs by countries – Europe, Germany, France, Italy, Spain, UK
  • Pulmonary Hypertension drugs sales forecast: Sales forecast for Pulmonary Hypertension drugs to 2021 by countries – Europe, Germany, France, Italy, Spain, UK, Japan
  • Pulmonary Hypertension market share analysis: Find out the market shares of Pulmonary Hypertension drugs and outlook by countries – Europe, Germany, France, Italy, Spain, UK, Japan
Benefits of this Research: The research helps executives to
  • Evaluate commercial market opportunities for Pulmonary Hypertension drugs
  • Synthesize insights for business development & licensing
  • Track market size, competitor drug sales, market shares in Pulmonary Hypertension market
  • Develop in-depth knowledge of competition and markets
  • Analyze sales data to update your brand planning trackers
  • Develop tactics and strategies to take advantage of opportunities in the market
  • Track market trends and analyze key events in Pulmonary Hypertension market
  • Develop forecast models, healthcare frameworks, or economic models
  • Answer key business questions; supports decision making in R&D to long term marketing strategies


1. Pulmonary Hypertension: Disease Overview
1.1. Pulmonary Hypertension Symptoms
1.2. Pulmonary Hypertension Etiology
1.3. Pulmonary Hypertension Diagnosis
1.4. Pulmonary Hypertension Treatment Options
2. Pulmonary Hypertension Pipeline Insights
2.1. Pulmonary Hypertension Phase 3 Clinical Trials
2.2. Pulmonary Hypertension Phase 2 Clinical Trials
2.3. Pulmonary Hypertension Phase 1 Clinical Trials
3. Pulmonary Hypertension Epidemiology Analysis
4. Germany Pulmonary Hypertension Market Insights
4.1. Marketed Products for Pulmonary Hypertension in Germany
4.2. Germany Pulmonary Hypertension Market Size & Forecast
4.3. Germany Pulmonary Hypertension Product Sales Forecast
4.4. Germany Pulmonary Hypertension Market Share Analysis
5. France Pulmonary Hypertension Market Insights
5.1. Marketed Products for Pulmonary Hypertension in France
5.2. France Pulmonary Hypertension Market Size & Forecast
5.3. France Pulmonary Hypertension Product Sales Forecast
5.4. France Pulmonary Hypertension Market Share Analysis
6. Italy Pulmonary Hypertension Market Insights
6.1. Marketed Products for Pulmonary Hypertension in Italy
6.2. Italy Pulmonary Hypertension Market Size & Forecast
6.3. Italy Pulmonary Hypertension Product Sales Forecast
6.4. Italy Pulmonary Hypertension Market Share Analysis
7. Spain Pulmonary Hypertension Market Insights
7.1. Marketed Products for Pulmonary Hypertension in Spain
7.2. Spain Pulmonary Hypertension Market Size & Forecast
7.3. Spain Pulmonary Hypertension Product Sales Forecast
7.4. Spain Pulmonary Hypertension Market Share Analysis
8. UK Pulmonary Hypertension Market Insights
8.1. Marketed Products for Pulmonary Hypertension in UK
8.2. UK Pulmonary Hypertension Market Size & Forecast
8.3. UK Pulmonary Hypertension Product Sales Forecast
8.4. UK Pulmonary Hypertension Market Share Analysis
9. Europe Pulmonary Hypertension Market Insights
9.1. Europe Pulmonary Hypertension Market Size & Forecast
9.2. Europe Pulmonary Hypertension Product Sales Forecast
9.3. Europe Pulmonary Hypertension Market Share Analysis
10. Research Methodology
LIST OF TABLES
Table 1: Pulmonary Hypertension Phase 3 Clinical Trials, Global, 2017
Table 2: Pulmonary Hypertension Phase 2 Clinical Trials, Global, 2017
Table 3: Pulmonary Hypertension Phase 1 Clinical Trials, Global, 2017
Table 4: Pulmonary Hypertension Prevalence by EU5 Countries, 2012 - 2021
Table 5: Marketed Products for Pulmonary Hypertension in Germany, 2017
Table 6: Germany Pulmonary Hypertension Market Size & Forecast ($mn), 2012 - 2021
Table 7: Germany Pulmonary Hypertension Product Sales ($mn), 2012 - 2021
Table 8: Germany Pulmonary Hypertension Market Trends, 2012 - 2021
Table 9: Marketed Products for Pulmonary Hypertension in France, 2017
Table 10: France Pulmonary Hypertension Market Size & Forecast ($mn), 2012 - 2021
Table 11: France Pulmonary Hypertension Product Sales ($mn), 2012 - 2021
Table 12: France Pulmonary Hypertension Market Trends, 2012 - 2021
Table 13: Marketed Products for Pulmonary Hypertension in Italy, 2017
Table 14: Italy Pulmonary Hypertension Market Size & Forecast ($mn), 2012 - 2021
Table 15: Italy Pulmonary Hypertension Product Sales ($mn), 2012 - 2021
Table 16: Italy Pulmonary Hypertension Market Trends, 2012 - 2021
Table 17: Marketed Products for Pulmonary Hypertension in Spain, 2017
Table 18: Spain Pulmonary Hypertension Market Size & Forecast ($mn), 2012 - 2021
Table 19: Spain Pulmonary Hypertension Product Sales ($mn), 2012 - 2021
Table 20: Spain Pulmonary Hypertension Market Trends, 2012 - 2021
Table 21: Marketed Products for Pulmonary Hypertension in UK, 2017
Table 22: UK Pulmonary Hypertension Market Size & Forecast ($mn), 2012 - 2021
Table 23: UK Pulmonary Hypertension Product Sales ($mn), 2012 - 2021
Table 24: UK Pulmonary Hypertension Market Trends, 2012 - 2021
Table 25: Europe Pulmonary Hypertension Market Size & Forecast ($mn), 2012 - 2021
Table 26: Europe Pulmonary Hypertension Product Sales ($mn), 2012 - 2021
LIST OF FIGURES
Figure 1: Pulmonary Hypertension Pipeline by Phase (%), Global, 2017
Figure 2: Pulmonary Hypertension Prevalence by EU5 Countries, 2012 - 2021
Figure 3: Germany Pulmonary Hypertension Market Size ($mn), 2012 - 2021
Figure 4: Germany Pulmonary Hypertension Product Sales ($mn), 2012 - 2021
Figure 5: Germany Pulmonary Hypertension Market Share by Products (%), 2016
Figure 6: Germany Pulmonary Hypertension Market - Future Market Share (%), 2021
Figure 7: France Pulmonary Hypertension Market Size ($mn), 2012 - 2021
Figure 8: France Pulmonary Hypertension Product Sales ($mn), 2012 - 2021
Figure 9: France Pulmonary Hypertension Market Share by Products (%), 2016
Figure 10: France Pulmonary Hypertension Market - Future Market Share (%), 2021
Figure 11: Italy Pulmonary Hypertension Market Size ($mn), 2012 - 2021
Figure 12: Italy Pulmonary Hypertension Product Sales ($mn), 2012 - 2021
Figure 13: Italy Pulmonary Hypertension Market Share by Products (%), 2016
Figure 14: Italy Pulmonary Hypertension Market - Future Market Share (%), 2021
Figure 15: Spain Pulmonary Hypertension Market Size ($mn), 2012 - 2021
Figure 16: Spain Pulmonary Hypertension Product Sales ($mn), 2012 - 2021
Figure 17: Spain Pulmonary Hypertension Market Share by Products (%), 2016
Figure 18: Spain Pulmonary Hypertension Market - Future Market Share (%), 2021
Figure 19: UK Pulmonary Hypertension Market Size ($mn), 2012 - 2021
Figure 20: UK Pulmonary Hypertension Product Sales ($mn), 2012 - 2021
Figure 21: UK Pulmonary Hypertension Market Share by Products (%), 2016
Figure 22: UK Pulmonary Hypertension Market - Future Market Share (%), 2021
Figure 23: Europe Pulmonary Hypertension Market Size ($mn), 2012 - 2021
Figure 24: Europe Pulmonary Hypertension Product Sales ($mn), 2012 - 2021
Figure 25: Europe Pulmonary Hypertension Market Share by Products (%), 2016
Figure 26: Europe Pulmonary Hypertension Market - Future Market Share (%), 2021

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report